U.S. FDA advisory meetings through Dec. 18

Bristol-Myers Squibb Co's (BMY.N) Abilify, Orencia and Reyataz; GlaxoSmithKline's (GSK.L) Argatroban and Ventolin HFA; Abbott Laboratories Inc's (ABT.N) Humira and Kaletra; Merck & Co's (MRK.N) Cancidas; Johnson & Johnson's (JNJ.N) Evicel fibrin sealant...